Revolutionary Cancer Drug Enhances Radiation Therapy Effectiveness
UC San Francisco scientists have developed a targeted radiation therapy that combines a cancer drug with a radioactive antibody to selectively destroy cancer cells, minimizing damage to healthy tissue. This approach, which effectively eliminated lung and bladder tumors in mice, uses a drug to flag cancer cells and a radioactive antibody to deliver precise radiation, potentially overcoming tumor resistance. The team is working on adapting this method for broader patient use by developing antibodies that account for individual cellular differences.